Not currently recruiting at University of California Health
Open-Label Surufatinib in European Patients With NET
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UC Irvine
- Dates
- study startedestimated completion
- Principal Investigator
- by Farshid Dayyani, MD (uci)
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Farshid Dayyani, MD (uci)
Clinical Professor, Medicine, School of Medicine. Authored (or co-authored) 66 research publications
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Hutchmed
- ID
- NCT04579679
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 76 study participants
- Last Updated